Threshold electrical stimulation (TES) in ambulant children with CP: a randomized double-blind placebo-controlled clinical trial

Research output: Contribution to journalJournal articleResearchpeer-review

  • Christine í Dali
  • Flemming Juul Hansen
  • Søren Anker Pedersen
  • Liselotte Skov
  • Hilden, Jørgen
  • Inge Bjørnskov
  • Charlotte Strandberg
  • Jette Christensen
  • Ulla Haugsted
  • Grethe Herbst
  • Ulla Lyskjaer
A randomized double-blind placebo-controlled clinical trial was carried out to determine whether a group of stable children with cerebral palsy (36 males, 21 females; mean age 10 years 11 months, range 5 to 18 years) would improve their motor skills after 12 months of threshold electrical stimulation (TES). Two thirds received active and one third received inactive stimulators. For the primary outcome we constructed a set of plausible motor function tests and studied the change in summary indices of the performance measurements. Tests were videotaped and assessed blindly to record qualitative changes that might not be reflected in performance measurements. We also judged range of motion, degree of spasticity, and muscle growth measured by CT. Fifty seven of 82 outpatients who were able to walk at least with a walker, completed all 12 months of treatment (hemiplegia n=25, diplegia n=32). There was no significant difference between active and placebo treatment in any of the tested groups, nor combined. Visual and subjective assessments favoured TES (ns), whereas objective indices showed the opposite trend. We conclude that TES in these patients did not have any significant clinical effect during the test period.
Original languageEnglish
JournalDevelopmental Medicine and Child Neurology
Issue number6
Pages (from-to)364-369
Number of pages5
Publication statusPublished - 2002

Bibliographical note

Keywords: Adolescent; Cerebral Palsy; Child; Child, Preschool; Double-Blind Method; Electric Stimulation Therapy; Female; Humans; Male; Motor Skills Disorders; Muscle, Skeletal; Placebos; Severity of Illness Index; Treatment Outcome

ID: 136509